Pharma/fine chemicals roundup—19 August 2014

3:12 AM MDT | August 19, 2014 | Deepti Ramesh

Perrigo's API segment reports fall in sales and operating profits The active pharmaceutical ingredient (API) business segment of Perrigo (Dublin) reports a 20.5% fall in sales in the company’s fiscal fourth quarter ended 28 June 2014, compared with the year-ago period, to $32.5 million. Operating profits for the API segment decreased 12% in the quarter, to $8.8 million. The API segment's fourth-quarter sales declined due primarily to a $17-million decrease in sales of existing products as a result of increased competition on certain products, partially...